KRON
$2.27
Kronos Bio
($.16)
(6.58%)
KRON
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  ($0.60)
Revenue:  N/A
Thursday
Feb 23
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KRON reports earnings?
Beat
Meet
Miss

Where is KRON's stock price going from here?
Up
Flat
Down
Stock chart of KRON
Analysts
Summary of analysts' recommendations for KRON
Score
Grade
Pivots
Resistance
$2.66
$2.56
$2.41

$2.31

Support
$2.16
$2.06
$1.91
Tweet
Growth
Description
Kronos Bio Inc. is a clinical-stage biopharmaceutical company. It engages in discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio Inc. is headquartered in San Mateo, Calif.